CI_ChemClass CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE Adrenergic alpha-Antagonists [MoA] Drug Hypersensitivity [Disease/Finding] Hypertension [Disease/Finding] Hypotension [Disease/Finding] Prostatic Hyperplasia [Disease/Finding] Raynaud Disease [Disease/Finding] Urinary Retention [Disease/Finding] Prazosin [Chemical/Ingredient] Quinazolines [Chemical/Ingredient] Arterial Vasodilation [PE] Decreased Bladder Sphincter Tone [PE] Venous Vasodilation [PE] PRAZOSIN HYDROCHLORIDE <VANDF_Record>50.416^1453^Active/Master</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>1453</VA_IEN><VA_Status>Active/Master</VA_Status> 203210 C0700578 Prazosin hydrochloride 盐酸哌唑嗪片 N0000147152 4018850 Ingredient X0Z7454B90 PRAZOSIN HYDROCHLORIDE C19108 PRAZOSIN Decreased Blood Pressure [PE] fatigue AE pancreatitis AE abdominal discomfort AE nasal congestion AE tachycardia AE fever AE rash AE pruritus AE headache AE dizziness AE paresthesia AE syncope AE sweating AE abdominal pain AE alopecia AE vertigo AE palpitation AE antinuclear antibody present AE depression AE epistaxis AE hallucination AE emotional liability AE edema AE arthritis AE nausea AE vomiting AE constipation AE urinary incontinence AE tinnitus AE diarrhea AE erectile dysfunction AE lichen planus AE pollakiuria AE scleral hyperemia AE hepatic function abnormal AE vision blurred AE tiredness AE priapism AE fecal incontinence AE orthostatic hypotension AE dazzling AE